Metsera

Developing next-gen obesity therapies

weight loss scale weigh measure tape obesity overweight
Biotech

Pfizer’s new prize Metsera touts 14% weight loss for GLP-1

The drug at the center of Pfizer’s buyout has been tied to 14.1% weight loss at 28 weeks as well as “potentially class-leading tolerability.”
James Waldron Sep 30, 2025 6:40am
Measuring tape on top of cash

Pfizer inks $4.9B Metsera buyout to beef up obesity pipeline

Sep 22, 2025 7:47am
obesity overweight weight loss weigh

Metsera posts amylin data, eyes monthly GLP-1 combo

Jun 9, 2025 7:00am
biotechs top money raisers hero image

Biotech's top money raisers: 2024

Mar 3, 2025 5:00am
Photo of Wall Street street sign with american flags in the background

Metsera, Maze go public with IPOs of $275M, $113M

Jan 31, 2025 7:40am
finance numbers tape money

Metsera eyes $289M IPO to fund phase 3 weight loss trial

Jan 27, 2025 11:00am